Contract services for toxicity testing
 |
STEMCELL Technologies’ Contract Assay Service works with you to develop and perform flexible custom-designed experiments that meet your unique needs and goals. By harnessing our industry-standard reagents and extensive stem cell biology expertise, you will enhance your ability to determine the potency and safety of compounds earlier in the drug development process, thereby saving valuable time and resources. Our experts have conducted more than 400 studies, and have helped over 80 organizations worldwide with their specific research needs.
A high failure rate of late stage drug candidates is cost prohibitive. Traditional drug discovery platforms based on in vitro animal, tumor, or genetically-transformed cell lines are often poorly representative of the human condition. Using human primary progenitor cells, we can help you obtain more clinically relevant data, which may significantly improve your drug candidate’s translation into the clinic.
Learn More |
Methylcellulose-based media for in vitro drug screening
Primary human cells
High throughput cell line development